INSMED Inc — Director's Dealing 2023

Jul 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-07-11

Reporting Person: Smith Michael Alexander (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-11	Common Stock	S	740	$20.18	Disposed	77142	Direct

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2: Includes 800 shares acquired through the Company's 2018 Employee Stock Purchase Plan.